Results 21 to 30 of about 86,105 (313)

If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study

open access: yesClinical Infectious Diseases, 2021
Background Rifampin is generally advised in the treatment of acute staphylococcal periprosthetic joint infections (PJI). However, if, when, and how to use rifampin remains a matter of debate.
M. Beldman   +12 more
semanticscholar   +1 more source

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection

open access: yesMicrobiology Spectrum, 2021
After staphylococci, streptococci and enterococci are the most frequent causes of periprosthetic joint infection (PJI). MICs and minimum biofilm bactericidal concentrations of rifampin, rifabutin, and rifapentine were determined for 67 enterococcal and ...
Mariana Albano   +7 more
doaj   +1 more source

Structural basis of rifampin inactivation by rifampin phosphotransferase [PDF]

open access: yesProceedings of the National Academy of Sciences, 2016
Significance Rifampin phosphotransferases (RPH) belong to a recently identified antibiotic-resistance protein family that inactivates rifampin, the first-line drug against tuberculosis, by phosphorylation. By determining the structures of RPH from Listeria monocytogenes (LmRPH) in different conformations ...
Xiaofeng Qi   +10 more
openaire   +3 more sources

Rifampin-Associated Renal Failure

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to ...
Kathleen Miller   +2 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis [PDF]

open access: yes, 2003
Patients in whom acid-fast bacilli smear-positive pulmonary tuberculosis was newly diagnosed were randomized to receive 400 mg moxifloxacin, 300 mg isonaizid, or 600 mg rifampin daily for 5 days. Sixteen-hour overnight sputa collections were made for the
Bongard, E   +7 more
core   +1 more source

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial

open access: yesJournal of Orthopaedic Surgery and Research, 2020
Background The evidence supporting rifampin combination therapy in prosthetic joint infections (PJI) is limited due to the lack of controlled studies.
Ø. E. Karlsen   +10 more
semanticscholar   +1 more source

Rifampin (INN Rifampicin) [PDF]

open access: yesJournal of Pain and Symptom Management, 2015
Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and
Mary Mihalyo   +5 more
openaire   +2 more sources

Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease. [PDF]

open access: yes, 2013
Mycobacterium ulcerans infection causes a neglected tropical disease known as Buruli ulcer that is now found in poor rural areas of West Africa in numbers that sometimes exceed those reported for another significant mycobacterial disease, leprosy, caused
A Bentoucha   +48 more
core   +6 more sources

Rifampin-resistant Meningococcal Disease

open access: yesEmerging Infectious Diseases, 2005
Rifampin-resistant meningococcal disease occurred in a child who had completed rifampin chemoprophylaxis for exposure to a sibling with meningococcemia. Susceptibility testing of 331 case isolates found only 1 other case of rifampin-resistant disease in ...
Jean Rainbow   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy